HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NO-donating aspirin inhibits the activation of NF-kappaB in human cancer cell lines and Min mice.

Abstract
Nitric oxide-donating aspirin (NO-ASA) is a promising agent for the control of cancer, whose mechanism of action remains unclear. NF-kappaB is an important signaling molecule in the pathogenesis of cancer. We studied in several human colon (HT-29, HCT-15, LoVo, HCT116 and SW-480), pancreatic (BxPC-3, MIA PaCa-2) and breast (MDA-MB-231 and MCF-7) cancer cell lines, the effect of NO-ASA on NF-kappaB activation, determined by electrophoretic mobility shift assays, immunofluorescence and western blot analyses of nuclear proteins. NO-ASA inhibited NF-kappaB activation, as early as 30 min and with IC(50)s ranging between 0.83 and 64 microM. Such inhibition was also observed at NO-ASA concentrations that had an insignificant or marginal effect on cell growth. The effect of NO-ASA on NF-kappaB binding to DNA was significantly correlated with its effect on cell growth (P < 0.05) indicating that the growth inhibitory effect of NO-ASA may be mediated by its effect on NF-kappaB. Compared with control, NO-ASA decreased NF-kappaB activation in intestinal epithelial cells of APC(min+/-) mice by 38.4% (P < 0.01). Western blot and immunofluorescence analyses revealed that the nuclear levels of the p50 and p65 NF-kappaB subunits were virtually unaffected, suggesting an inhibitory mechanism different from suppressed subunit translocation into the nucleus. Inhibition of NF-kappaB activation by NO-ASA may account, at least in part, for its chemopreventive efficacy.
AuthorsJennie L Williams, Ping Ji, Nengtai Ouyang, Xiaoping Liu, Basil Rigas
JournalCarcinogenesis (Carcinogenesis) Vol. 29 Issue 2 Pg. 390-7 (Feb 2008) ISSN: 1460-2180 [Electronic] England
PMID18174252 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antineoplastic Agents
  • NF-kappa B
  • NF-kappa B p50 Subunit
  • Transcription Factor RelA
  • Nitric Oxide
  • Aspirin
Topics
  • Adenocarcinoma (metabolism)
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Aspirin (pharmacology)
  • Cell Line, Tumor
  • Cell Proliferation
  • Female
  • Humans
  • Kinetics
  • Mice
  • Mice, Transgenic
  • NF-kappa B (metabolism)
  • NF-kappa B p50 Subunit (metabolism)
  • Nitric Oxide
  • Transcription Factor RelA (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: